Clinical Trial Update: A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Motexafin Gadolinium in combination with Docetaxel and Cisplatin for non-small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Motexafin Gadolinium (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Non-Small-Cell Lung Carcinoma, Carcinoma, Bronchogenic | Phase 1 | Status: COMPLETED